Prevent cancer preclinical drug development program: cgmp
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N91024D00008
- Awardee
-
Curia Bio Inc. UEI PW5LPREDN9N5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- Prevent IDIQ mato RFP Pre-Solicitation · 75N91023R00024 · Posted Dec 19, 2022
- Last date to order 48% complete
- IDV ceiling
- $149,995,000.00
- Maximum order
- $149,995,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Cancer Institute awarded a single-award indefinite-delivery contract to Curia Bio Inc. on September 16, 2024, with a ceiling value of $149,995,000 and an ultimate completion date of January 24, 2029. The contract supports the PREVENT Cancer Preclinical Drug Development Program under Executive Order 14398.
The contract encompasses three distinct IDIQ pools: evaluating efficacy and biomarkers for chemopreventive and immunopreventive regimens; preclinical product development and CGMP manufacturing for cancer preventive vaccines; and pharmacological and toxicological testing of potential cancer preventative agents. Work is performed at Curia Bio's facilities in Albany, New York.
The originating pre-solicitation was posted on December 19, 2022, with responses due February 6, 2023, and an initial award date of January 25, 2024. No set-aside was used for this procurement.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N91024D00008?
75N91024D00008 was awarded to Curia Bio Inc. by National Cancer Institute (National Institutes of Health) on September 16, 2024.
How much is contract 75N91024D00008 worth?
75N91024D00008's own ceiling is $149,995,000. A single order can be worth up to $149,995,000.
Who can order from contract 75N91024D00008?
75N91024D00008 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N91024D00008 competed?
The extent of competition for 75N91024D00008 was full and open competition. The government received 2 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV